BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30284206)

  • 1. Non-adenomatous sellar lesions: single-centre 10-year experience.
    Sousa Santos F; Nunes Dias L; Henriques V; Canas Marques C; Chorão M; Sequeira Duarte J; Limbert C; Costa J; Graça J; Vasconcelos C; Cabral J; Ramos S
    Hormones (Athens); 2018 Dec; 17(4):557-563. PubMed ID: 30284206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-adenomatous sellar lesions: experience of a single centre and review of the literature.
    Koutourousiou M; Kontogeorgos G; Seretis A
    Neurosurg Rev; 2010 Oct; 33(4):465-76. PubMed ID: 20480381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and postoperative need for pituitary hormone replacement in non-adenomatous sellar and parasellar lesions: importance of the sellar encroachment score.
    Waqar M; Rampersad S; Bennett D; Kearney T; Gnanalingham KK
    Acta Neurochir (Wien); 2020 Oct; 162(10):2371-2379. PubMed ID: 32506330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of nonpituitary sellar lesions in a large surgical series.
    Valassi E; Biller BM; Klibanski A; Swearingen B
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):798-807. PubMed ID: 20874772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
    Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
    Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients.
    Famini P; Maya MM; Melmed S
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1633-41. PubMed ID: 21470998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary xanthogranulomas: clinical features, radiological appearances and post-operative outcomes.
    Ved R; Logier N; Leach P; Davies JS; Hayhurst C
    Pituitary; 2018 Jun; 21(3):256-265. PubMed ID: 29363000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, radiological and pathological features of patients with Rathke's cleft cysts: tumors that may recur.
    Mukherjee JJ; Islam N; Kaltsas G; Lowe DG; Charlesworth M; Afshar F; Trainer PJ; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2357-62. PubMed ID: 9215319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of magnetic resonance imaging in the diagnosis of lesions in the sellar region.
    Yin Y; Tong D; Yuan TT; Zhao XE
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):492-6. PubMed ID: 23134826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes insipidus secondary to sellar/parasellar lesions.
    Angelousi A; Mytareli C; Xekouki P; Kassi E; Barkas K; Grossman A; Kaltsas G
    J Neuroendocrinol; 2021 Mar; 33(3):e12954. PubMed ID: 33769630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric sellar tumors: diagnostic procedures and management.
    Jagannathan J; Dumont AS; Jane JA; Laws ER
    Neurosurg Focus; 2005 Jun; 18(6A):E6. PubMed ID: 16048292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of pediatric sellar lesions.
    Jagannathan J; Dumont AS; Jane JAJ
    Front Horm Res; 2006; 34():83-104. PubMed ID: 16474217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gangliocytomas of the sellar region: A challenging diagnosis.
    Cossu G; Daniel RT; Messerer M
    Clin Neurol Neurosurg; 2016 Oct; 149():122-35. PubMed ID: 27521460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign brain tumors: sellar/parasellar tumors.
    Jagannathan J; Kanter AS; Sheehan JP; Jane JA; Laws ER
    Neurol Clin; 2007 Nov; 25(4):1231-49, xi. PubMed ID: 17964033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sellar and suprasellar region: A "hideaway" of rare lesions. Clinical aspects, imaging findings, surgical outcome and comparative analysis.
    Petrakakis I; Pirayesh A; Krauss JK; Raab P; Hartmann C; Nakamura M
    Clin Neurol Neurosurg; 2016 Oct; 149():154-65. PubMed ID: 27540757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical outcomes in 31 patients with craniopharyngiomas extending outside the suprasellar cistern: an evaluation of the frontobasal interhemispheric approach.
    Shirane R; Ching-Chan S; Kusaka Y; Jokura H; Yoshimoto T
    J Neurosurg; 2002 Apr; 96(4):704-12. PubMed ID: 11990811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sellar surprises: a single-centre experience of unusual sellar masses.
    Thakkar K; Ramteke-Jadhav S; Kasaliwal R; Memon SS; Patil V; Thadani P; Lomte N; Sankhe S; Goel A; Epari S; Goel N; Lila A; Shah NS; Bandgar T
    Endocr Connect; 2020 Feb; 9(2):111-121. PubMed ID: 31910151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of cystic lesions in sella through transsphenoidal endoscopic endonasal approach: retrospective analysis of 46 cases].
    Yu H; Liu G
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 May; 50(5):369-73. PubMed ID: 26178046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrasellar tuberculoma--a difficult diagnosis.
    Páramo C; de la Fuente J; Nodar A; Miramontes S; Quintela JL; García-Mayor RV
    Infection; 2002 Jan; 30(1):35-7. PubMed ID: 11876514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative sellar hematoma after pituitary surgery: clinical and biochemical characteristics.
    El-Asmar N; El-Sibai K; Al-Aridi R; Selman WR; Arafah BM
    Eur J Endocrinol; 2016 May; 174(5):573-82. PubMed ID: 26850446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.